Related Experiment Video
Updated: Feb 26, 2026

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Interleukin-32 in chronic inflammatory conditions is associated with a higher risk of cardiovascular diseases
Michelle S M A Damen1, Calin D Popa2, Mihai G Netea1
1Department of Internal Medicine, Radboud Center for Infectious Diseases (RCI), Geert Grooteplein Zuid 8, 6525GA Nijmegen, The Netherlands.
Insights
Interleukin-32 (IL-32) may link chronic inflammation to cardiovascular diseases (CVD). This cytokine influences inflammatory pathways and may contribute to atherosclerosis, increasing CVD risk in inflammatory conditions.
Area of Science:
- Immunology
- Cardiology
- Inflammation research
Background:
- Cardiovascular diseases (CVD) are a leading cause of mortality, particularly in individuals with chronic inflammatory conditions.
- Inflammatory status significantly contributes to the development and stability of atherosclerotic plaques, underlying CVD pathogenesis.
- Emerging evidence implicates Interleukin-32 (IL-32) in processes relevant to both inflammation and atherosclerosis.
Purpose of the Study:
- To review recent advances concerning the role of IL-32 in chronic inflammatory disorders.
- To explore the potential involvement of IL-32 in the elevated prevalence of CVD observed in patients with inflammatory conditions.
Main Methods:
- Literature review of recent studies on IL-32.
- Analysis of IL-32's modulation of key inflammatory pathways (e.g., TNFα, IL-6, IL-1β).
- Examination of IL-32's suggested effects on endothelial function and high-density lipoprotein (HDL) levels.
Main Results:
- IL-32 modulates critical inflammatory pathways implicated in inflammatory diseases and atherosclerosis.
- IL-32 may influence endothelial cell function.
- Potential impact of IL-32 on serum high-density lipoprotein (HDL) concentrations.
Conclusions:
- IL-32 is a potential mediator linking chronic inflammatory disorders to increased cardiovascular disease risk.
- Further research into IL-32's role could offer new therapeutic targets for managing CVD in inflammatory conditions.
Abstract:
Cardiovascular diseases (CVD) are the most frequent cause of death in developed countries. Their prevalence is higher in several chronic inflammatory conditions. This is likely due to the substantial contribution of the inflammatory status of the patients to the development and stability of atherosclerotic plaques. Recent evidence suggests that interleukin (IL)-32 may be involved in the conditions that contribute to CVD. IL-32 not only modulates important inflammatory pathways known to contribute to the pathogenesis of both inflammatory diseases and atherosclerosis, including tumor necrosis factor (TNF)α, IL-6 or IL-1β, but it has been also suggested to modulate endothelial cell function and the serum concentration of high-density lipoprotein (HDL). In this review, we highlight the recent advances in the field of IL-32 in relation to chronic inflammatory disorders and argue for a role of IL-32 in the increased prevalence of CVD in these patients.
More Related Videos
12:50Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
Published on: September 15, 2017
07:48Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation
Published on: May 16, 2016
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inflammation
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Psychoneuroimmunology: Diabetes and Cancer
The JAK-STAT Signaling Pathway